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Structural and biochemical 
characterisation of Archaeoglobus 
fulgidus esterase reveals a bound 
CoA molecule in the vicinity of the 
active site
Christopher Sayer1, William Finnigan1, Michail N. Isupov1, Mark Levisson2, 
Servé W. M. Kengen2, John van der Oost2, Nicholas J. Harmer1 & Jennifer A. Littlechild1
A new carboxyl esterase, AF-Est2, from the hyperthermophilic archaeon Archaeoglobus fulgidus has 
been cloned, over-expressed in Escherichia coli and biochemically and structurally characterized. 
The enzyme has high activity towards short- to medium-chain p-nitrophenyl carboxylic esters with 
optimal activity towards the valerate ester. The AF-Est2 has good solvent and pH stability and is very 
thermostable, showing no loss of activity after incubation for 30 min at 80 °C. The 1.4 Å resolution 
crystal structure of AF-Est2 reveals Coenzyme A (CoA) bound in the vicinity of the active site. 
Despite the presence of CoA bound to the AF-Est2 this enzyme has no CoA thioesterase activity. The 
pantetheine group of CoA partially obstructs the active site alcohol pocket suggesting that this ligand 
has a role in regulation of the enzyme activity. A comparison with closely related α/β hydrolase fold 
enzyme structures shows that the AF-Est2 has unique structural features that allow CoA binding. A 
comparison of the structure of AF-Est2 with the human carboxyl esterase 1, which has CoA thioesterase 
activity, reveals that CoA is bound to different parts of the core domain in these two enzymes and 
approaches the active site from opposite directions.
Archaeoglobus fulgidus is an anaerobic heterotrophic sulfate reducing archaeon1 that grows at temperatures 
between 60 and 95 °C, with optimal growth at 83 °C. The enzymes from thermophilic microorganisms have high 
potential for use as new industrial biocatalysts due to their naturally high stability to temperature and organic 
solvents2,3.
The esterases are a class of enzymes that catalyse the cleavage of ester bonds and have been extensively used 
in many important biotechnology applications4. These include the synthesis of optically pure compounds in the 
agriculture, food and pharmaceutical industries5 and the degradation of natural materials and pollutants, plas-
tics and other industrial waste products6,7. Features such as high stability in organic solvents8, broad substrate 
specificity9 and high regio- and stereo-selectivity10 make these enzymes attractive biocatalysts. Specific examples 
include the use of aryl esterases in the development of flavours in the food and beverage industries11, and the use 
of the Bacillus carboxyl esterase NP for the production of the nonsteroidal drug naproxen12.
The lipolytic enzymes are made up from two main groups13: the true lipases (EC 3.1.1.3; triacylglycerol 
lipases) and the esterases (EC 3.1.1.1; carboxylesterases). Enzymes of both groups catalyse the cleavage of an ester 
into a carboxylic acid and an alcohol. The esterases hydrolyse water soluble esters with a short fatty acid chain, 
while lipases show preference for insoluble fatty acid esters with a chain length greater than ten carbon units. The 
esterases obey classical Michaelis-Menten kinetics and have a relatively open active site. In contrast, the lipases 
use the process of interfacial activation where a hydrophobic lid domain moves away from the active site in the 
presence of a minimum concentration of a lipid substrate. Most lipolytic enzymes belong to the α /β hydrolase 
protein fold superfamily. However, esterase activity has been reported for enzymes with a β lactamase fold14 and 
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an α /β /α hydrolase fold15 or as a side activity for the carbonic anhydrase enzymes16. The ESTHER database17 
divides the α /β hydrolase enzymes into over 140 families and superfamilies which are further assigned to groups 
C, H, L, and X.
The proposed mechanism of catalysis by the α /β hydrolase lipolytic enzymes resembles the serine protease 
mechanism18. This involves the substrate binding with the carbonyl oxygen adjacent to the oxyanion hole. The 
catalytic acidic residues and histidine activate the catalytic serine hydroxyl which performs nucleophilic attack on 
the carbonyl carbon of the scissile bond to produce the tetrahedral intermediate. Subsequently the alcohol prod-
uct is released and an acyl-enzyme complex is formed. After an attack by a water molecule another tetrahedral 
intermediate is formed which resolves to release the carboxyl product and the free enzyme. The catalytic serine 
residue in the α /β hydrolase fold esterases is usually located in a tight nucleophilic elbow with the consensus 
sequence Gly-X-Ser-X-Gly, although deviations from this consensus have been reported19.
Many examples of thermophilic esterases have previously been described, including enzymes from 
Thermotoga maritima20,21, Geobacillus stearothermophilus22,23, Alicyclobacillus acidocaldarius24, Thermobifida 
fusca25, Sulfolobus tokadaii26, Rhizomucor miehei9, amongst others. To date two esterases and a lipase from A. fulg-
idus have been reported. The AFEST27 (locus tag: AF1716) is a member of the hormone-sensitive-lipase family 
and has a preference for the substrate pNP-caprylate. The crystal structure of this enzyme (PDB: 1JJI) revealed 
several thermophilic adaptations with an increased secondary structure content, reduction in loop extensions 
and an increase in intramolecular ion pairs compared to a mesophilic homologue28. The second esterase Est-AF29 
(locus tag: AF2336) showed optimal activity towards pNP-butyrate and no activity for substrates with a carboxyl 
group larger than caprylate. This enzyme has been applied in the resolution of ketoprofen ethyl esters. Extensive 
mutagenesis of Est-AF resulted in an enzyme with improved activity for the production of the S-enantiomer of 
ketoprofen30. The biocatalytic synthesis of poly(δ -valerolactone) using AFEST has also recently been demon-
strated31. The alkaliphilic A. fulgidus lipase32 (locus tag: AF1763) is also thermostable at 70–90 °C.
Here, we report the biochemical and structural characterisation of a third esterase from the A. fulgidus 
genome, named AF-Est2 (locus tag: AF1537). This belongs to the α /β hydrolase 6 family and the X group of the 
ESTHER classification. This enzyme was biochemically characterised and shown to be highly thermostable and 
stable in organic solvents and at extremes of pH. The X-ray structure of the AF-Est2 was determined and reveals 
the presence of a molecule of Coenzyme A (CoA). This is bound in a unique position in the vicinity of the enzyme 
active site groove, partially obstructing the alcohol binding pocket. AF-Est2 shows a novel utilisation of CoA 
where the pantetheine moiety could act as a regulatory function for enzyme activity.
Results and Discussion
Substrate specificity. The AF-Est2 enzyme was successfully cloned and over-expressed in Escherichia coli 
and purified using a nickel affinity column and size exclusion chromatography. AF-Est2 was tested against a range 
of p-nitrophenyl (pNP) esters and was shown to be active against small to medium acyl chain length esters (C2 
to C8), which is consistent with its classification as an esterase rather than a lipase. AF-Est2 showed optimum 
activity against pNP-valerate with a kcat of 58.9 ± 0.2 s−1 and a KM of 19 ± 1 μ M (Table 1). The kcat values are close 
for the whole range of acyl ester chain lengths and differences in the catalytic efficiency of the enzyme are due 
to large differences in the KM for these different substrates. AF-Est2 was also active against the substrate methyl 
p-toluate which other tested carboxyl esterases are inactive against. Kinetic constants were determined using a 
phenol red assay giving a KM of 1500 ± 100 μ M with kcat of 1.23 ± 0.07 s−1, 0.94 ± 0.02 s−1 and 0.08 ± 0.006 s−1 
at 70 °C, 50 °C and 30 °C respectively. This shows the enzyme is able to accommodate industrially relevant bulky 
aromatic carboxylate groups.
Enzyme stability and activity at elevated temperatures. To test the temperature tolerance of 
AF-Est2, it was incubated at elevated temperatures for 30 min and then cooled to room temperature before being 
assayed. No loss of activity was observed after incubation at temperatures up to 80 °C. This is close to the opti-
mum growth temperature of A. fulgidus. As the incubation temperature was increased past this point the enzyme 
became progressively denatured, retaining no activity after incubation at 95 °C (Fig. 1A). The temperature opti-
mum for activity of AF-Est2 was determined by performing the assay at increasing temperatures. The activity 
increased with temperature following the Arrhenius equation up to a maximum of 80 °C. A high level of sponta-
neous substrate hydrolysis prevented measurement of activity beyond 80 °C.
kcat (s−1) KM (μM) kcat/K M (s−1 μM−1)
C2 21.5 ± 0.2 620 ± 10 0.0349 ± 0.0007
C3 47.8 ± 0.5 254 ± 8 0.189 ± 0.006
C4 55.5 ± 0.5 92 ± 3 0.61 ± 0.02
C5 58.9 ± 0.2 19 ± 1 3.1 ± 0.2
C8 46.0 ± 0.3 120 ± 10 0.37 ± 0.03
C12 0 N/A 0
Benzoate 0 N/A 0
Table 1.  The kinetic characterisation of AF-Est2 using pNP-esters with varying acyl chain length and pNP-
benzoate as substrates. No activity was detected for substrates with an acyl chain length of twelve carbons or 
more.
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Activity was also measured whilst incubating AF-Est2 at 70 °C, 50 °C and 30 °C for an extended time period. 
AF-Est2 was able to retain over 50% activity for one week at 70 °C showing the enzyme would be an excellent 
choice for applications where an elevated temperature may be required for solubilisation of industrial substrates 
or where enzyme stability under reactions conditions is an issue. At 30 °C and 50 °C an excess of 50% activity 
remained after 20 days.
Enzyme stability and activity at different pHs. Features adopted by proteins for stability at high tem-
peratures often allow them to withstand other denaturing conditions such as extremes of pH, presence of organic 
solvents and proteolysis. We therefore tested the activity of AF-Est2 at pH 7.5 after incubation for one hour at a 
range of different pH values. No significant change in activity was observed for all incubation pH values between 
3.0 and 12.0, showing that the enzyme is stable across an unusually wide range of pH values (Fig. 1B). Incubation 
at pH 2.0 caused inactivation of the enzyme. Activity assays for AF-Est2 at different pHs showed that the enzyme 
is active over a broad range of pH values from 5.0 to 11.0 with optimum activity at pH 9.0.
Solvent stability. The residual activity of the AF-Est2 was tested after incubation in a range of common 
organic solvents. The enzyme retained activity in nearly all of the solvent conditions after incubation for 1 hour 
in buffer containing 25 mM Tris-HCl pH 7.5, 100 mM NaCl, and either 10%, 25% or 50% of methanol, ethanol, 
isopropanol, DMSO, acetonitrile and acetone. Only incubation in 50% isopropanol was significantly detrimental 
to the enzyme activity resulting in 23% relative activity when compared to the control. As with the stability of 
AF-Est2 at extremes of pH, adaptions for thermal stability allow the enzyme to withstand the denaturing effects 
of a range of organic solvents.
Inhibitors. To assist in determining the mechanism of AF-Est2, the effect of common hydrolase inhibitors on 
the enzyme was tested. The serine protease inhibitors phenylmethysulfonyl fluoride (PMSF) and benzamidine 
and the carboxylesterase inhibitor benzil were used in a range of concentrations up to 2 mM. Both reversible 
inhibitors benzamidine and benzil showed no effect on the reaction rate of AF-Est2 after incubation for half an 
hour. To fully inhibit AF-Est2, incubation with 100 μ M PMSF for 30 min was required. When PMSF was added 
Figure 1. The biochemical characterisation of AF-Est2. (A) The effects of temperature on AF-Est2. Blue 
triangles  show the relative activity of AF-Est2 with increasing temperature, relative to a maximum activity at 
80 °C. Red circles  show the relative activity of AF-Est2 incubated for half an hour at various temperatures, 
against a control kept at room temperature. The insert shows the linearity of the Arrhenius plot of the relative 
activity with increasing temperature. (B) The effects of pH on AF-Est2. Blue triangles  show the relative 
activity of AF-Est2 at various pH values, relative to its maximum activity at pH 9.0. Red circles  show the 
activity of AF-Est2 after incubation at various pH values for an hour, before assaying under standard conditions.
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during the enzymatic reaction a significantly lower inhibition of the enzyme was observed. This would suggest 
that the substrates or products compete with the PMSF for binding in the active site of the enzyme.
Investigating the kinetics of the enzyme inhibition with different concentrations of PMSF (Fig. 2A) revealed 
the mode of inhibition to be mixed, with a KI of 1.0 ± 0.3 μ M and an Alpha value of 0.3 ± 0.1. A small Alpha value 
suggests PMSF acts more as an uncompetitive inhibitor than a competitive inhibitor, again suggesting an unusual 
mode of inhibition for this enzyme33.
Structural determination. AF-Est2 was crystallized in the space group P212121 with cell dimensions of 
a = 55.6 Å, b = 67.6 Å, c = 139.5 Å, α = β = γ = 90°. The asymmetric unit contains two protein monomers each 
with a molecular mass of 28.1 kDa giving a solvent content of 46%. The structure has been isotropically refined 
to a resolution of 1.4 Å with a final Rfree of 17.5 (Table 2). Several data sets were collected in an attempt to get 
protein-ligand complexes from crystals soaked or co-crystallised with pNP esters, benzyl, benzamidine and 
PMSF. Data for putative pNP-valerate and PMSF complexes were collected to high resolution, but contained no 
density for the bound ligand.
The structure reveals, as expected, a canonical α /β  hydrolase fold core domain (Asp1-Arg117 and 
Asp176-His254), and a cap domain (Leu118-Phe175) formed by helices α 5-α 8 (Fig. 3). Six helices of the core 
domain surround an eight stranded β -sheet of mixed type with connectivity 1,2,− 1x,2x,1x,1x,1x with direction 
+ − + + + + + + . The catalytic Ser89 residue in both molecules of AF-Est2 is an outlier on the Ramachandran 
plot. The strained conformation of the catalytic serine residue is observed in the structures of most other α /β 
hydrolase fold enzymes34. There are no residues in a cis conformation in AF-Est2. The structure also contains 
two CoA molecules at full occupancy, several ordered PEG molecules and a single citrate molecule bound at a 
Figure 2. Inhibition of AF-Est2. (A) The effect of increasing concentrations of PMSF on the kinetics of AF-
Est2 with pNP-valerate. Initial rates with varying concentrations of PMSF are displayed as follows: 0 μ M PMSF 
by , 0.1 μ M PMSF by , 0.2 μ M PMSF by , 0.4 μ M PMSF by  and 0.8 μ M PMSF by . The 
data has been fitted to the mixed model inhibition equation and the following parameters calculated. 
KCAT = 59 ± 0.7 s−1, KM = 18 ± 1 μ M, KI = 1.0 ± 0.3 μ M and α = 0.3 ± 0.1 μ M. A small alpha value suggests 
PMSF acts more as an uncompetitive inhibitor, which is reflected when the data is shown as a Lineweaver-Burk 
plot. (B) The relative activity of AF-Est2 after incubation with various concentrations of diamide over time, 
shown as 100 mM , 10 mM  and 1 mM . The activity is relative to a control sample with no 
diamide. Error bars show the standard error of three replicates.
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crystal contact. This citrate ligand originates from the crystallisation solution and could have contributed to the 
formation of more ordered crystals.
Although the asymmetric unit of AF-Est2 contains two monomers, these do not form oligomers in the crystal. 
This is in agreement with the chromatography results where the protein eluted as a monomer from a calibrated 
size exclusion column.
Ligand assignment. When most of the AF-Est2 model was built using the original 2.1 Å resolution data, 
a significant stretch of continuous density became apparent on both the 2Fo − Fc and the Fo − Fc maps in the 
proximity of the AF-Est2 catalytic triad in both monomers. Modelling of a bound polypeptide did not produce a 
convincing match to the observed density. A molecule of CoA provided the best fit for the un-assigned density. 
Refinement at the higher resolution of 1.4 Å confirmed the full occupancy of this CoA ligand in the AF-Est2 
structure (Fig. 4A).
The CoA binding groove. The pantetheine group of the CoA points directly into the active site. The remain-
der of the CoA molecule is bound in a groove on the surface of the enzyme (Fig. 4B,C). This groove is formed by 
the loop region consisting of residues 116–121, preceding α 5 on one side and the loop region of residues 202–207 
which precedes α 9 on the other side. There is an ion pair formed by the diphosphate moiety of the CoA and the 
guanidinium group of Arg117. The residues Arg119 and Arg182 could also form ion pairs with the diphosphate 
and phosphate groups of CoA, respectively, but do not do so in this structure. The CoA also forms several specific 
H-bonds and hydrophobic interactions. The adenine ring of CoA is stacked in a pocket between the side chains 
of Tyr207 and Leu178 (Fig. 4B) and its N6A atom makes a H-bond to the main chain oxygen of Arg117. The 
side chain of Lys206 is H-bonded to O2B of the ribose ring of CoA. The N4P and O5P of the pantetheine group 
of the CoA are H-bonded to main chain oxygen of Leu202 and the main chain nitrogen of Leu121, respectively. 
It appears that the CoA has a high affinity for the enzyme and is tightly bound since no CoA was added during 
Crystal COA complex
Beamline (Diamond) I03
Resolution (Å) 70.29-1.40 (1.44-1.40)a
Wavelength (Å) 0.9763
Space group P212121
Cell dimensions a, b, c = 55.1, 67.2, 140.6 Å; α , β , γ = 90°
No. of protomers in A.U. 2




< (I)/ σ (I)> 18.9 (2.0)
Rsym (%) 4.4 (46.1)
Wilson B factor (Å2) 24.5
Overall R-factor (%) 15.6
Rfree (5% total data) % 17.3
Residues refined 508
No. of waters modelled 514
RMSD bond length (Å) 0.011 [0.019]b
RMSD bond angle (°) 1.6 [2.0]
Occupancy of ligand 1.0
Average B factor
 Protein (Å2) 22.8
 Water (Å2) 35.5
 Ligand 24.8
Ramachandran analysis (% of residues)
 Most favoured 88.7
 Additionally allowed 10.9
 Generously allowed 0.0
 Disallowed 0.4
G-factor 0.1
Table 2.  The AF-Est2 data processing and structural refinement statistics. aValues for the outer 
resolution shell are given in parentheses. bTarget values are given in brackets. Rsym = ∑ h∑ J| < Ih > − IJ(h) 
|/∑ h∑ J IJ(h), where I(h) is the intensity of the reflections h, ∑ h is the sum over all the reflections and ∑ J is 
the sum over J measurements of the reflections. The individual atomic B-factors were refined isotropically. 
Rcryst = ∑ ||Fo| − |Fc||/∑ |Fo|. Wilson B-factor was estimated by SFCHECK59. The Ramachandran plot analysis 
and G-factor calculation were performed by PROCHECK60.
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expression or purification of the enzyme. Extensive dialysis of the purified enzyme did not remove the CoA mol-
ecule which may contribute to the high thermostability observed for this enzyme.
The NCBI reference sequence database contains about twenty protein sequences from both archaeal and bac-
terial sources with higher than 35% sequence identity to AF-Est2 over more than 90% of its length. Residues that 
are involved in CoA binding in AF-Est2 are either conserved or conservatively replaced in the majority of these 
enzymes. This suggests that these other enzymes could also bind CoA, however, in the absence of their biochemi-
cal or structural characterization this cannot be determined. The structure of the AF-Est2 described in this paper 
is the first example to show the binding of CoA to an esterase enzyme in this conformation.
Since the AF-Est2 binds CoA this enzyme could have a role in reversible hydrolysis of CoA esters. However, 
no activity was observed towards the common CoA esters, acetyl-CoA and succinyl-CoA (data not shown) con-
firming that AF-Est2 does not function as a thioesterase. If CoA esters were a substrate for AF-Est2 they would 
have moderate affinity for the enzyme to allow the rapid dissociation of the product CoA which would not bind 
as tightly to the enzyme as observed in these studies. It therefore appears that the tightly bound CoA acts as an 
integral part of the enzyme.
Active site. The active site is located at the interface of the core and the cap domains with the conserved 
catalytic triad composed of Ser89, His228 and Asp200. The catalytic serine is in a strained conformation and 
is located in a tight nucleophilic elbow at the end of strand β 5 with the conserved esterase signature sequence 
Gly-His-Ser-Leu-Gly.
A comparison of the structure of AF-Est2 with structures of the ligand complexes of other proteins of the α /β 
hydrolase family 6, allows prediction of its active site pockets. The carboxyl binding pocket of AF-Est2 is likely to 
be formed by the loop region between β 3 and α 1, and helices α 5, α 6 and α 7. The side chains of residues Met229, 
Lys154, Phe158, Leu140, Met139 and Ser32, with Phe158 and Lys154, are responsible for defining the size of the 
carboxyl ester group to be hydrolysed. This largely hydrophobic pocket defines the enzyme’s optimal activity 
towards pNP-valerate (Table 1). The residues Lys154 and Phe158 (helix α 7), at the far end of the carboxyl binding 
pocket, restrict the chain length of the substrate that can be hydrolysed. It appears that movement of these side 
chains would be required for the binding of the caprylate chain, which would explain the lower levels of affinity 
of AF-Est2 towards this pNP-ester (Table 1). The enzyme’s affinity towards the pNP-acetate and pNP-propionate 
is also relatively low, which appears to be due to the reduced binding interactions available in the active site for 
these substrates.
CoA obstructs the alcohol binding pocket of the active site. The hydrophobic alcohol pocket is 
formed by the side chains of residues Leu118, Val120, Leu169 and Cys172, and is partially obstructed by the 
pantetheine group of the CoA. The alcohol pocket is responsible for binding the pNP moiety of the associated 
substrates. The predicted binding of the pNP moiety is thought to be provided by the main chain region of helix 
α 6 between the side chains of Val120 and Leu169. For successful pNP ester hydrolysis, displacement of the pan-
tetheine group of the CoA would be required, since modelling has shown it to be a major steric hindrance for the 
binding of the relatively large pNP group in the alcohol pocket. However high activity of AF-Est2 towards the 
pNP esters suggests that the flexible CoA pantetheine group is displaced from the alcohol pocket upon substrate 
binding.
Figure 3. A cartoon representation of the AF-Est2 structure showing the core and cap domains in dark 
green and light green respectively, with the bound CoA molecule shown as a stick model. The catalytic triad 
residues are shown as stick models and the active site is highlighted as a yellow box. Figures 3, 4a,c, 5 and 6 were 
prepared using PyMol Molecular Graphics System (Schrödinger LLC).
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Thiol oxidation inhibits AF-Est2 activity towards pNP esters. The thiol group of CoA is located 
around 4 Å away from the thiol group of Cys172 in AF-Est2 and would form a disulfide bond with Cys172. The 
Figure 4. The interactions of the CoA ligand bound to AF-Est2. (A) A stereo diagram showing the electron 
density maps in the region of the CoA binding to AF-Est2. The 2Fo − Fc (blue) is contoured at 1.2 σ and the 
Fo − Fc map is contoured at 3.5 σ (green) and − 3.2 σ (red). The ligand and amino acid residues are shown 
as stick models. Solvent molecules are shown as red crosses, a Cl− ion is shown as a green cross. (B) A stereo 
diagram showing the CoA binding site of AF-Est2. The CoA molecule is shown as a stick model with carbon 
atoms coloured in green. Amino acid side chains of residues implicated in the ligand binding are coloured 
in light blue with hydrogen bonds shown as black dashes. The Figure 4b was prepared using CCP4 mg58. (C) 
The electrostatic potential surface of the AF-Est2 CoA complex. The positive charge is shown in blue and the 
negative charge is shown in red. The ligand molecule was not used in the surface calculation and is shown as a 
stick model.
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necessity of the CoA pantetheine group displacement for pNP ester hydrolysis was confirmed by incubation of the 
AF-Est2 with the disulfide inducing agent diamide which enforces the formation of a covalent bond between the 
thiol groups of CoA and Cys172 (Fig. 2B). This oxidised enzyme shows no activity towards pNP-valerate demon-
strating that this enzyme is inhibited by the formation of the disulfide. Modelling studies suggest that hydrolysis 
of substrate esters with small alcohol groups (methyl or ethyl) may not be inhibited by the disulfide formation.
Since the AF-Est2 does not have a signal sequence it is assumed to be a cytosolic protein, with reduced 
disulfides. It would appear that the CoA ligand may control the levels of activity of AF-Est2 towards carboxyl 
esters since activity towards esters with larger alcohol groups will be reduced due to the partial obstruction of 
the active site by the CoA. It is possible that AF-Est2 could have evolved from an ancestral protein with CoA 
thioesterase activity.
Comparison of AF-Est2 with related enzymes of the α/β hydrolase family. The AF-Est2 belongs 
to the α /β hydrolase family 6 in the Pfam classification35. The enzymes of this family are reported to catalyse a 
variety of different reactions. Examples include a Pseudomonas fluorescens esterase36, bacterial non-heme halop-
eroxidases37, the Burkholderia xenovorans 3-oxodipate enol lactonase38 and Aureobacterium (− ) γ -lactamase39. 
Depending on the features of the active site and the type of reaction that is catalysed, some of the enzymes have 
esterase activity.
The closest sequence homologues of AF-Est2 in the structural database are the C-C bond hydrolases such 
as the tetrameric Mhcp40 from E. coli (PDB 1U2E) and the tetrameric meta-cleavage product (MCP) hydrolase 
(Hsad) from Mycobacterium tuberculosis41 (PDB 2VF2). The latter enzyme (with only 27% identity to AF-Est2 
over 95% of the amino acid sequence) catalyses the hydrolytic cleavage of a C-C bond in an intermediate of cho-
lesterol metabolism and is also capable of catalysing ester bond hydrolysis in vitro41. The active site Ser114Ala 
mutation of Hsad has allowed elucidation of the conformational changes of the enzyme structure which accom-
pany the substrate binding42 (PDB 2WUF). The relative positions of the cap and core domains differ between 
Hsad and AF-Est2 which causes a shift of the helix α 8 by 6.5 Å towards the catalytic triad in AF-Est2 (Fig. 5A). 
The helices α 5, α 6 and α 7 of the cap domain of AF-Est2 are shifted by approximately 3 Å in relation to their 
equivalent helices in the Hsad structure. The loop region between the core and the cap domain is involved in 
the CoA binding in AF-Est2. This loop is significantly longer in Hsad and occupies the space of the CoA groove 
in AF-Est2. The differences of the cap domain positions would prevent the binding of the MCP substrates to 
AF-Est2. In Hsad, the active site entrance on the interface of the domains is open in the absence of ligand and 
partially closes in its presence42. However, it is much more closed in AF-Est2, even when the obstructing CoA 
molecule is not taken into account. The shorter loop region between helices α 8 and α 9 in AF-Est2 would restrict 
the relative secondary structure movements observed in the Hsad enzyme.
The MCP hydrolases have two conserved sub-sites: a hydrophilic polar sub-site binding a substrate dienoate 
moiety, and a non-polar sub-site binding the hydrophobic part of the molecule. The different position of helix α 8 
and the loops connecting the core and the cap domains would not allow AF-Est2 to form such a non-polar bind-
ing site. The polar binding site responsible for MCP hydrolase activity also shows low conservation of both the 
positioning of the main chain backbone and the amino acid sequence in this region. Therefore, it is not expected 
that AF-Est2 would have C-C hydrolase activity.
AF-Est2 also shares 27% identity (over 79% of the amino acid sequence) with the monomeric E. coli BioH 
carboxyl esterase43 (PDB 1M33), an enzyme involved in biotin biosynthesis. The enzyme has a preference for 
carboxyl esterase activity towards short acyl chain substrates and has weak thioesterase activity43. Whilst the core 
domains of the two enzymes superimpose closely, there is a relative movement of the helices α 5-α 8 that comprise 
the cap domain. The relative movement of the core and the cap domains between the model and the target could 
be the reason why an MR solution could not be found for AF-Est2 using Hsad and BioH as models, despite their 
greater sequence similarity.
AF-Est2 and BioH display little structural conservation in the active site region. One of the two helices in 
BioH which define the carboxyl pocket (α 5) is displaced 5 Å away from the active site in AF-Est2 and the other 
(α 6), which defines the far edge of the pocket, is in a different orientation. BioH shows optimal activity towards 
pNP-acetate and pNP-propionate with lower activities observed for pNP-butyrate and pNP-caprylate. In contrast, 
AF-Est2 shows a similar activity towards acetate and a much greater activity towards pNP-propionate and opti-
mal activity towards pNP-valerate. The side chains of Gln147 (equivalent Ala143 in AF-Est2), Trp81 (His88) and 
Leu24 (Ser32) give BioH a more restrictive carboxyl binding pocket compared to AF-Est2, thereby explaining the 
difference in substrate specificity between the two enzymes.
Using the Dali lite server44, AF-Est2 shows best structural alignment to an enol lactonase38 (RMSD 2.2 Å; PDB 
2XUA) and a carboxyl esterase from a newly isolated thermophilic Planctomyces species, Thermogutta terrifontis 
(TtEst; RMSD 2.5 Å) recently described by our group45. The core domains between TtEst and AF-Est2 superim-
pose closely and the relative positions of the core and the cap domains are similar (Fig. 5B). However, helices α 5 
and α 8 are displaced in AF-Est2 compared to the TtEst.
The carboxyl binding pocket in AF-Est2 occupies a larger volume than that in TtEst. This is consistent with 
AF-Est2′ s preference towards larger butyrate and valerate esters for which the TtEst shows limited activity45. 
Mutagenesis studies in TtEst have confirmed that Leu37 hinders the binding of esters with side chains larger than 
propionate. The corresponding Ser32 in AF-Est2 allows binding of the larger carboxyl side chains. Although most 
of the residues in the carboxyl pocket are not conserved between AF-Est2 and TtEst, they both are predominantly 
hydrophobic.
The 3-oxodipate enol lactonase and (− ) γ -lactamase, which both are active only towards pNP-acetate, have 
bulky Trp side chains obstructing the binding of the longer chain substrates in the carboxyl pocket.
www.nature.com/scientificreports/
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The alcohol pocket in AF-Est2 is significantly smaller than that of TtEst and the 3-oxodipate enol lactonase. 
This is due to obstruction by the panthotheine group of the CoA molecule and to the different position of helix α 5.
Comparison of CoA binding with another α/β hydrolase fold thioesterase. Since the results pre-
sented in this paper suggest that the AF-Est2 has inherited the CoA binding from an ancestral protein with 
thioesterase activity, it is interesting to compare this ligand binding in AF-Est2 with other proteins of the α /β 
hydrolase fold family. Since only a relatively small proportion of CoA thioesterases have the α /β hydrolase fold, 
a search of the PDB revealed a single enzyme of this family which also binds CoA. This human carboxyl esterase 
1 (PDB 2DQZ and 2H7C) is involved in cholesterol ester hydrolysis, fatty acyl CoA hydrolysis, acyl-CoA:choles-
terol acyl transfer, and fatty acyl ethyl ester synthesis46. The monomer of the hexameric human enzyme is twice 
as large as AF-Est2; however, the core domains of the two proteins superimpose well. In contrast, the cap domain 
of the human esterase has no similarity to the cap domain of AF-Est2 and contains three distinct ligand binding 
sites. The mode of binding of the CoA ligand to one of these sites in the human carboxyl esterase shares little sim-
ilarity to that observed in AF-Est2 (Fig. 6). In AF-Est2, the CoA molecule is bound in the groove on the surface 
between the C-terminal part of the core domain and the cap domain. In the human carboxyl esterase the CoA 
binds between the N-terminal part of the core domain and the extended cap domain. This results in the panteth-
eine groups of CoA coming into the enzyme active sites of AF-Est2 and human carboxyl esterase 1 from opposite 
directions. These differences confirm that AF-Est2 shows an entirely novel form of CoA binding and suggests that 
this enzyme has evolved to utilise the pantetheine group of CoA as an integral part of its active site.
Conclusions
The AF-Est2 esterase structure has shown a novel binding mode for a CoA molecule which is located in a groove 
overlapping the active site of the enzyme where the pantetheine moiety is partially obstructing the alcohol bind-
ing pocket. This suggests that the CoA may have a role in reducing activity towards esters with a large alcohol 
group. The AF-Est2 does not appear to be related to the α /β hydrolase fold eukaryotic carboxyl esterases that also 
bind CoA. The structures of AF-Est2 and human carboxyl esterase reveal that the pantetheine group approaches 
Figure 5. A comparison of the overall fold of AF-Est2 with that of related proteins. (A) A stereo diagram 
showing the superposition of AF-Est2 (green) with the open form of Hsad (magenta; PDB 2VF2). The core 
domains are shown as transparent cartoon models and the cap domains are shown as full colour cartoon 
models. The AF-Est2 cap domain restrains the size of the ligand capable of binding to the enzyme active site. 
The CoA ligand is shown as a stick model. (B) A stereo diagram showing the superposition of AF-Est2 (green) 
with the malate complex of the TtEst (PDB 4UHE). The core domains are shown as transparent cartoon 
models and the cap domains are shown as full colour cartoon models. The relative positions of the core and cap 
domains are more similar between AF-Est2 and TtEst, than between AF-Est2 and Hsad. The ligands CoA and 
the malate which maps the alcohol binding pocket in TtEst are shown as stick models.
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the active site from opposite directions between the two enzymes. The AF-Est2 enzyme is so far unique in its 
mode of binding of CoA and could represent the first example of a new group of esterases. The AF-Est2 reported 
here shows no thioesterase activity despite the fact that it could have evolved from an ancestral protein with CoA 
thioesterase activity.
The detailed biochemical and structural comparisons of AF-Est2 with other related Pfam family 6 α /β hydro-
lase enzymes as reported in this paper is of general interest from the aspect of natural enzyme evolution which has 
occurred within this large enzyme family.
The AF-Est2 esterase from the thermophilic archaeon Archaeoglobus has potential applications in industrial 
biocatalysis due to its overall stability to high temperature, a broad pH range and tolerance to organic solvents.
Methods
Expression and purification. The gene encoding AF-Est2 (locus tag: AF1537; Uniprot acces-
sion number: O28735) was PCR-amplified, without its stop codon, using chromosomal DNA of A. fulg-
idus as a template and the two primers 5′-GCGCCATGGACCTGGAGAGAGTATTCATCG-3′  and 
5′-GGGCTCGAGAACCCCAACTTTTTTGAGAAACTTTTCAAGCGC-3′, introducing respectively a NcoI and 
XhoI restriction site. The generated PCR product was digested by NcoI and XhoI and the product was purified and 
ligated into the protein expression vector pET24d (EMD Millipore) digested with the same restriction enzymes, 
resulting in the plasmid pWUR365 for the expression of the C-terminal 6x-His-tag AF-Est2 protein.
The pWUR365 vector was transformed into the E. coli strain BL21-CodonPlus (DE3)-RIPL (Agilent) cells 
which were grown on Luria-Bertani (LB) medium containing 50 μ g/ml each of kanamycin, chloramphenicol 
and streptomycin for protein expression. Cultures were grown at 37 °C, 225 rpm until approximately OD600 0.6, 
at which point protein expression was induced by the addition of 1 mM IPTG. The cultures were left shaking at 
30 °C for a further 18 hours. Cells were harvested by centrifugation and resuspended in 20 mM Tris-HCl pH 8.0, 
10 mM imidazole. Cell lysis was achieved by sonication on ice followed by centrifugation. AF-Est2 was purified 
using a 1 ml His-Trap FF crude column (GE Healthcare) using an elution gradient from 20 to 500 mM imidazole 
in 20 mM Tris-HCl pH 8.0, 0.5 M NaCl. The enzyme was then applied to a calibrated Superdex 200 HiLoad 16/60 
size exclusion column (GE Healthcare) and was eluted with one column volume of a buffer of 25 mM Tris-HCl, 
pH 7.5, 0.1 M NaCl.
Standard assays. Assays were carried out using pNP ester substrates as previously described47. A 50 mM 
stock of each substrate in DMSO was prepared and stored at − 80 °C until required. Unless otherwise specified, 
each reaction was performed in assay buffer containing 50 mM Tris-HCl pH 7.5, 1 mM substrate, 0.125 μ g/ml of 
enzyme and carried out in triplicate in standard 96-well microplates (Greiner 655101). Reactions were started by 
the addition of substrate after pre-incubation at 30 °C for 5 min, and monitored by following the absorbance at 
405 nm over 10 min in a Tecan Infinite M200 PRO plate reader. All activity measurements included a reading for 
the blank rate of hydrolysis which was subtracted from the observed activity, compensating for any autohydrolysis 
of the pNP esters.
The molar extinction coefficient of pNP was determined for every condition prior to measurements. One Unit 
of esterase activity was defined as the amount of protein releasing 1 μ mol/min of pNP.
To measure the CoA thioesterase activity a DTNB-based assay48, which measures the level of free thiols (and 
hence formed CoA) was performed following incubation of the enzyme with acetyl-CoA and succinyl-CoA.
Substrate specificity and kinetics. Kinetic analysis of substrate specificity was carried out by measuring 
the activity of AF-Est2 against a range of pNP esters (C2 to C12 and pNP-benzoate) over a range of ten substrate 
concentrations from 5 to 2500 μ M. The initial reaction rates were fitted to the Michaelis-Menten equation by 
non-linear least squares regression using GraphPad Prism 5.0.
Phenol red was used to monitor the change in pH as a result of the hydrolysis of the industrial substrate 
methyl p-toluate by the change in absorbance at 540 nM. The 1 ml assay was prepared using 20 μ g/ml phenol 
red, 1 mM HEPES pH 8.0 at each assay temperature. A spectrophotometer with a Peltier temperature controller 
Figure 6. A comparison of the CoA binding to both AF-Est2 (cyan) and human carboxylesterase 1 
(magenta) shown as cartoon models in the same orientation. The core domains are shown as transparent 
models and the cap domains are shown in full colour. The CoA ligands bound to the two proteins are shown as 
ball-and-stick models with carbon atoms coloured in grey. The CoA molecules bind to different parts of the core 
domain in these two proteins and their panthetheine groups come into the enzyme active site from the different 
directions.
www.nature.com/scientificreports/
1 1Scientific RepoRts | 6:25542 | DOI: 10.1038/srep25542
was used for assays at 50 °C and 70 °C with 13.6 μ g/ml of enzyme. Assays at 30 °C were carried out in a standard 
96-well microplate reader in a 200 μ l volume with 25.0 μ g/ml of enzyme. All assays were carried out for 10 min 
after addition of the substrate. A standard curve from 0 to 300 μ M of p-toluic acid was generated for each assay 
temperature. Activity was measured at eight concentrations of methyl p-toluate between 0 and 5000 μ M and the 
initial reaction rates were fitted as described above.
Effects of temperature. The thermostability of AF-Est2 was assessed by incubating samples at a range 
of temperatures for half an hour using the temperature gradient function of a T100 thermocycler (Bio-Rad). 
Following incubation samples were cooled to 4 °C before assaying activity against pNP-valerate, relative to a con-
trol sample kept at room temperature.
To examine the effect of temperature on the activity of AF-Est2, a standard assay buffer was prepared and 
titrated to the correct pH at temperatures from 20 °C to 80 °C. Using an Evolution 300UV-Vis spectrophotometer 
(Thermo Scientific) with a Peltier heater, 970 μ l of assay buffer was equilibrated to temperature in a 1 ml quartz 
cuvette. The blank rate with 0.5 mM pNP-valerate was measured before the addition of 0.125 μ g of enzyme. A 
10 min continuous assay was performed and the data analysed to use only initial linear rates.
To measure the stability of AF-Est2 at 70 °C, 50 °C and 30 °C aliquots of AF-Est2 were prepared at 1 mg/ml in 
25 mM HEPES pH 7.5, 100 mM NaCl and 0.01% sodium azide. Every few days 0.2 μ g of enzyme was taken from 
each aliquot was used to measure activity against 0.5 mM pNP-valerate in triplicate, with rates calculated relative 
to those at the beginning of the experiment.
Effects of pH. To test the stability of AF-Est2 at various pHs, AF-Est2 was incubated for one hour at room 
temperature in the following buffers covering a range of pH values from 2 to 12: 100 mM KCl-HCl pH 2.0, 
100 mM glycine-HCl pH 3.0, 100 mM sodium acetate pH 4.0 and pH 5.0, 100 mM sodium phosphate pH 6.0, 
100 mM Tris-HCl pH 7.0, pH 8.0 and pH 9.0, 100 mM glycine-NaOH pH 10.0, 100 mM sodium dihydrogen 
orthophosphate-NaOH pH 11.0 and pH 12.0. The enzyme was then diluted 250 fold into 50 mM Tris-HCl pH 7.5, 
to a final concentration of 2.5 μ g/ml, and assayed against pNP-caprylate (C8).
To access the effect of pH on enzyme activity, reactions were carried out using the buffers described above in 
place of the standard reaction buffer. The pNP-caprylate was used as the substrate to reduce spontaneous hydrol-
ysis at alkaline pHs. Readings were taken at 348 nm, the isobestic point of pNP, to remove the effect of pH on the 
readings.
Effect of solvents. To examine the stability of AF-Est2 in various solvents, the enzyme was incubated 
for 1 hour in buffer containing 25 mM Tris-HCl pH 7.5, 100 mM NaCl, and either 10%, 25% or 50% solvent. 
Methanol, ethanol, isopropanol, DMSO, acetonitrile and acetone were tested. A control sample was incubated 
with no solvent to compare relative activity. Samples were then diluted 1 in 2000 in assay buffer to measure 
enzyme activity.
Effect of inhibitors. The inhibitors PMSF, benzamidine and benzil at concentrations in the 0–2 mM range 
were incubated with enzyme at 9 nM for 30 min before measuring enzyme activity by the addition of the sub-
strate, 0.5 mM pNP-valerate.
The mode of PMSF inhibition was determined using Michaelis-Menten kinetics with eight different 
pNP-valerate concentrations in the presence of five inhibitor concentrations. The best equation to describe the 
inhibition data was selected by fitting a non-linear least squares regression in GraphPad Prism 5.0.
Diamide treatment. 0.25 mg/ml enzyme was incubated in a 1, 10 or 100 mM diamide, 25 mM Tris-HCl pH 
7.5, 100 mM NaCl solution for 1 hour before a 1 in 250 dilution into 25 mM Tris-HCl pH 7.5, 100 mM NaCl was 
made. A control incubation was also performed without the addition of diamide. Enzyme assays were performed 
as specified previously against pNP-valerate. Activity was calculated as relative to the control sample.
Crystallization. AF-Est2 was concentrated to ~12 mg/ml using a 10 kDa membrane Vivaspin (Vivaproducts) 
and microbatch crystallization trials were set up using an Oryx6 crystallization robot (Douglas Instruments) 
using the JCSG Screen+ ™ (Molecular Dimensions). The droplet contained a 50:50 ratio of protein solution to 
screen and was covered with Al’s oil (50:50 mix of silicon and paraffin oils) before being stored at 20 °C.
Native crystals appeared within one week in 100 mM ammonium chloride and 10% (w/v) PEG3350 and were 
cooled in liquid N2 using a cryoprotectant consisting of 100 mM ammonium chloride, 10% (w/v) PEG3350, 
35% (v/v) PEG400, 25 mM Tris pH 7.5 and 100 mM NaCl. Multiple attempts of inhibitor and substrate 
co-crystallisation produced crystals in conditions related to those of native crystals. Additionally, native crystals 
were soaked for 30–300 sec in the cryoprotectant containing variable concentrations of ligands.
X-ray data collection and structure solution. Native AF-Est2 data were collected to 2.1 Å and later to 
1.4 Å on beamline I03, at the Diamond Synchrotron light source (Didcot, UK) at 100 K in a stream of gaseous 
nitrogen using a Pilatus detector (Dectris). Data were processed and scaled using XDS49 and AIMLESS50 in the 
Xia251 pipeline. All further data and model manipulation was carried out using the CCP4 suite of programs52.
Phases for the initial structure were determined using these 2.1 Å resolution data by the molecular replace-
ment method implemented in the MORDA pipeline (Vagin and Lebedev; http://www.biomexsolutions.co.uk/
morda). The best solution was found with the bromoperoxidase A1 monomeric model37 (PDB 1A8Q) which 
shares 27% sequence identity to AF-Est2. Two monomers of the search model were positioned in the AF-Est2 unit 
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cell with a Z-score of 9.6 and in the course of initial refinement Rfree was reduced from 57.6% to 51.9%. MORDA 
has estimated the probability of the resulting solution to be correct at 81%.
The phases were improved by two fold NCS averaging using DM53. The averaged phases were used in phased 
refinement implemented in the REFMAC554. The combined partial model and averaged phases produced a good 
quality map that allowed re-building of AF-Est2 structure in COOT55. The unknown ligand was identified as CoA 
at this stage.
Refinement with both anisotropic and isotropic B-factors was attempted since for 1.4 Å the ratio of independ-
ent reflections to refined atoms (including alternative conformations) is 20, which is a borderline case for ani-
sotropic B-factor refinement according to PDB REDO56. After the map inspection isotropic B-factor refinement 
was selected.
The statistics of the data processing and parameters of the final refined models are given in Table 2. The 
dictionary definitions for pNP ester ligands used for docking were prepared using JLIGAND57 and the manual 
docking of ligands was performed in COOT.
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